Femura Pharmaceuticals Private Limited, a active private limited company, was established on 19 September 2014 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230KA2014PTC076514. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹2.00 M.
It upholds a active non-compliant status. Employing 26 professional, Its leadership includes Subramaniam Arathi (Director), Chandrashekar Hosahithlu Vinay Kumar (Director), Krishna Manoj Chandra (Additional Director). It holds ₹1.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at No. 77/2, Dvg Road, Basavanagudi, Bangalore, Karnataka, 560004.
U24230KA2014PTC076514
076514
19 September 2014
₹3.00 M
₹2.00 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Femura Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subramaniam Arathi | Director | 19 Sep 2014 | Current |
| Chandrashekar Hosahithlu Vinay Kumar | Director | 01 Sep 2020 | Current |
| Krishna Manoj Chandra | Additional Director | 26 Mar 2015 | Current |
| Bindu Bakul Mehta | Director | 19 Sep 2014 | Current |
| Hariharan Krishnamurthy | Additional Director | 26 Mar 2015 | Current |
| Rameshbabu Dwaraknath | Additional Director | 26 Mar 2015 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Femura Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 11.26% decrease. The company also saw a slight decrease in profitability, with a 5.18% decrease in profit. The company's net worth moved up by a moderate rise of 4.87%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Femura Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹10,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Feb 2018 | State Bank Of India | ₹1.00 Cr | Open |
Explore comprehensive loan charge details -
Femura Pharmaceuticals has a workforce of 26 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Femura Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Femura Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Femura Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was completed.
Femura Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Bangalore. was recorded as a recent event.
The activity Chandrashekar Hosahithlu Vinay Kumar was appointed as a Director was appointed as a Director on 01 Sep 2020 & has been associated with this company since 5 years 3 months . was completed.
Progress on A charge with State Bank Of India amounted to Rs. 10.00 M with Charge ID 100174233 was registered on 08 Feb 2018. was documented.
The activity Krishna Manoj Chandra was appointed as a Additional Director was appointed as a Additional Director on 26 Mar 2015 & has been associated with this company since 10 years 8 months . was completed.
Progress on Hariharan Krishnamurthy was appointed as a Additional Director was appointed as a Additional Director on 26 Mar 2015 & has been associated with this company since 10 years 8 months . was documented.
The CIN of Femura Pharmaceuticals Private Limited is U24230KA2014PTC076514.
Femura Pharmaceuticals Private Limited is headquartered at No. 77/2, Dvg Road, Basavanagudi, Bangalore, Karnataka, 560004.
Femura Pharmaceuticals Private Limited was incorporated on 19 September 2014.
The current directors of Femura Pharmaceuticals Private Limited are
The primary industry of Femura Pharmaceuticals Private Limited is Manufacturing.
Femura Pharmaceuticals Private Limited is unlisted.
The authorized capital of Femura Pharmaceuticals Private Limited is ₹3.00 M, and the paid-up capital is ₹2.00 M.
The compliance status of Femura Pharmaceuticals Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX